Hospital psychiatric comorbidity and its role in heroin dependence treatment outcomes using naltrexone implant or methadone maintenance

Journal of Psychopharmacology

Volumn 25, Issue 6, 2011, Pages 774-782

  Ngo, Hanh Tt ^a   Tait, Robert J ^a,b   Hulse, Gary K ^a  

^a UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^b AUSTRALIAN NATIONAL UNIVERSITY   (Australia)

Author keywords

heroin dependence; methadone maintenance; naltrexone implant; Psychiatric comorbidity; treatment outcomes

Indexed keywords

METHADONE; NALTREXONE; OPIATE;

ADULT; ANXIETY; ARTICLE; COHORT ANALYSIS; COMORBIDITY; CONTROLLED STUDY; DEPRESSION; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DRUG IMPLANT; FEMALE; HEROIN DEPENDENCE; HOSPITALIZATION; HUMAN; LIFESPAN; LONGITUDINAL STUDY; MAINTENANCE THERAPY; MAJOR CLINICAL STUDY; MALE; MENTAL DISEASE; PERSONALITY DISORDER; PREDICTION; PREVALENCE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RETROSPECTIVE STUDY; RISK ASSESSMENT; SEX DIFFERENCE; TREATMENT OUTCOME;

ADULT; AUSTRALIA; DIAGNOSIS, DUAL (PSYCHIATRY); DRUG IMPLANTS; FEMALE; HEROIN DEPENDENCE; HOSPITALIZATION; HUMANS; LONGITUDINAL STUDIES; MALE; MENTAL DISORDERS; METHADONE; NALTREXONE; OPIATE SUBSTITUTION TREATMENT; PREVALENCE;

EID: 79960551165     PISSN: 02698811     EISSN: 14617285     Source Type: Journal    
DOI: 10.1177/0269881110364266     Document Type: Article

References (34)

1. Brooner RK, King VL, Kidorf M, Schmidt CW, Bigelow GE. Psychiatric and substance use comorbidity in treatment-seeking opioid abusers. Arch Gen Psychiatry. 1997 ; 54: 71-80 (Pubitemid 27044701)
2. Cacciola JS, Alterman AI, Rutherford MJ, McKay JR, Mulvaney FD. The relationship between psychiatric comorbidity to treatment outcomes in methadone maintained patients. Drug Alcohol Depend. 2001 ; 61: 271-280 (Pubitemid 32119308)
3. Compton WM, Cottler LB, Jacobs JL, Ben-Abdallah A, Spitznagel EL. The role of psychiatric disorders in predicting drug dependence treatment outcomes. Am J Psychiatry. 2003 ; 160: 890-895 (Pubitemid 41079573)
4. Conway KP, Compton W, Stinson FS, Grant B. Lifetime comorbidity of DSM-IV mood and anxiety disorders and specific drug use disorders: Results from the National Epidemiologic Survey on Alcohol and Related Conditions. J Clin Psychiatry. 2006 ; 67: 247-257 (Pubitemid 43357471)
5. Darke S, Hall W, Swift W. Prevalence, symptoms and correlates of antisocial personality disorder among methadone maintenance clients. Drug Alcohol Depend. 1994 ; 34: 253-257 (Pubitemid 24091672)
6. Darke S, Kaye S, Finlay-Jones R. Antisocial personality disorder, psychopathy and injecting heroin use. Drug Alcohol Depend. 1998 ; 52: 63-69 (Pubitemid 28448704)
7. Darke S, Ross J, Williamson A, Mills KL, Harvard A, Teesson M. Borderline personality disorder and persistently elevated levels of risk in 36-month outcomes for the treatment of heroin dependence. Addiction. 2007 ; 102: 1140-1146 (Pubitemid 46918678)
8. Drug and Alcohol Office (2006a) Western Australia Clinical Policies and Procedures for the use of Methadone and Buprenorphine in the Treatment of Opioid Dependence. In: Drug and Alcohol Office Government of Western Australia, (ed.), Perth, WA: Drug and Alcohol Office (WAADA), 1-105.
9. Drug and Alcohol Office (2006b) DAO 2006 Annual Report, Section B. Government of Western Australia. Available at: http://www.dao.health.wa.gov.au/ Publications/tabid/99/DMXModule/427/Default.aspx?EntryId=620 (accessed 17 February 2010).
10. Gelkopf M, Weizman T, Melamed Y, Adelson M, Bleich A. Does psychiatric comorbidity affect drug abuse treatment outcome? A prospective assessment of drug abuse, treatment tenure and infectious diseases in an Israeli methadone maintenance clinic. Isr J Psychiatry Relat Sci. 2006 ; 43: 126-136 (Pubitemid 44090655)
11. Gerra G, Leonardi C, D'Amore A, et al. Buprenorphine treatment outcome in dually diagnosed heroin dependent patients: A retrospective study. Prog Neuropsychopharmacol Biol Psychiatry. 2006 ; 30: 265-272 (Pubitemid 43288065)
12. Hesse M. Achieving abstinence by treating depression in the presence of substance-use disorders. Addict Behav. 2004 ; 29: 1137-1141 (Pubitemid 38962339)
13. Holman CDJ, Bass AJ, Rouse IL, Hobbs MST. Population-based linkage of health records in Western Australia: development of a health services research linked database. Aust N Z J Public Health. 1999 ; 23: 453-459 (Pubitemid 29479210)
14. Hulse GK, Arnold-Reed DE, O'Neil G, Chan CT, Hansson R, O'Neil P. Blood naltrexone and 6-b-naltrexol levels following naltrexone implant: comparing two naltrexone implants. Addict Biol. 2004 ; 9: 59-65 (Pubitemid 38608487)
15. Hulse GK, Morris N, Arnold-Reed D, Tait RJ. Improving clinical outcomes in treating heroin dependence. Arch Gen Psychiatry. 2009 ; 66: 1108-1115
16. Kessler RC, Nelson CB, McGonagle KA, Edlund MJ, Frank RG, Leaf PJ. The epidemiology of co-occurring addictive and mental disorders: implications for prevention and service utilization. Am J Orthopsychiatry. 1996 ; 66: 17-31 (Pubitemid 26031236)
17. King VL, Kidorf MS, Stoller KB, Carter JA, Brooner RK. Influence of antisocial personality subtypes on drug abuse treatment response. J Nerv Ment Dis. 2001 ; 189: 593-601 (Pubitemid 32910241)
18. Kosten TA, Kosten TR, Rounsaville BJ. Personality disorders in opiate addicts show prognostic specificity. J Subst Abuse Treat. 1989 ; 6: 163-168 (Pubitemid 19220638)
19. Longo MC, Henry-Edwards SM, Humeniuk RE, Christine P, Ali RI. Impact of the heroin 'drought' on patterns of drug use and drug-related harms. Drug Alcohol Rev. 2004 ; 23: 143-150 (Pubitemid 38907017)
20. McLellan AT, Luborsky L, Woody GE, O'Brien CP, Druley KA. Predicting response to alcohol and drug abuse treatments. Arch Gen Psychiatry. 1983 ; 40: 620-625
21. Maremmani I, Pacini M, Lubrano S, et al. Long-term outcomes of treatment-resistant heroin addicts with and without DSM-IV Axis 1 psychiatric comorbidity (dual diagnosis). Eur Addict Res. 2008 ; 14: 134-142 (Pubitemid 351841865)
22. Musselman DL, Kell MJ. Prevalence and improvement in psychopathology in opioid dependent patients participating in methadone maintenance. J Addict Dis. 1995 ; 14: 67-82
23. Ngo HT, Tait R, Arnold-Reed D, Hulse GK. Mental health outcomes following naltrexone implant treatment for heroin dependence. Prog Neuropsychopharmacol Biol Psychiatry. 2007 ; 31: 605-612 (Pubitemid 46467038)
24. Ngo HT, Arnold-Reed DE, Hansson RC, Tait RJ, Hulse GK. Blood naltrexone levels over time following naltrexone implants. Prog Neuropsychopharmacol Biol Psychiatry. 2008a ; 32: 23-28
25. Ngo HT, Tait RJ, Hulse GK. Comparing drug-related hospital morbidity following heroin dependence treatment with methadone maintenance or naltrexone implant. Arch Gen Psychiatry. 2008b ; 65: 457-465 (Pubitemid 351519895)
26. Nunes EV, Sullivan MA, Levin FR. Treatment of depression in patients with opiate dependence. Biol Psychiatry. 2004 ; 56: 793-802 (Pubitemid 39539838)
27. Ouimette PC, Finney JW, Moos RH. Two-year posttreatment functioning and coping of substance abuse patients with posttraumatic stress disorder. Psychol Addict Behav. 1999 ; 13: 105-114 (Pubitemid 29283898)
28. Regier DA, Farmer ME, Rae DS, et al. Comorbidity of mental disorders with alcohol and other drug abuse: Results from the epidemiologic catchment area (ECA) Study. JAMA. 1990 ; 264: 2511-2518
29. Rounsaville BJ, Weissman MM, Crits-Christoph K, Wilber C, Kleber H. Diagnosis and symptoms of depression in opiate addicts. Course and relationship to treatment outcome. Arch Gen Psychiatry. 1982 ; 39: 151-156 (Pubitemid 12178987)
30. Rounsaville BJ, Kosten TR, Weissman MM, Kleber H. Prognostic significance of psychopathology in treated opiate addicts. A 2.5-year follow-up study. Arch Gen Psychiatry. 1986 ; 43: 739-745 (Pubitemid 16035158)
31. Rounsaville BJ, Dolinsky ZS, Babor TF, Meyer RE. Psychopathology as a predictor of treatment outcome in alcoholics. Arch Gen Psychiatry. 1987 ; 44: 505-513 (Pubitemid 17082090)
32. Strain EC. Assessment and treatment of comorbid psychiatric disorders in opioid-dependent patients. Clin J Pain. 2002 ; 18 (Suppl). S14 - S27
33. Trafton JA, Minkel J, Humphreys K. Opioid substitution treatment reduces substance use equivalently in patients with and without posttraumatic stress disorder. J Stud Alcohol. 2006 ; 67: 228-235 (Pubitemid 43279672)
34. Verthein U, Degkwitz P, Haasen C, Krausz M. Significance of comorbidity for the long-term course of opiate dependence. Eur Addict Res. 2005 ; 11: 15-21 (Pubitemid 40082206)